Notice of Results

20th Sep 2012 14:59

Silence Therapeutics Notice of Results

London, UK, 20 September 2012 -Silence Therapeutics plc (AIM: SLN), a leading global RNA interference therapeutics company, will issue its interim financial results for the six months ended 30 June 2012 on Tuesday, 25 September 2012.

--Ends--

For further information, please contact:

Silence Therapeutics Ali Mortazavi +44 7768 694739

[email protected]

Jerry Randall +44 7990 502000

[email protected]

Singer Capital Markets M:Communications Shaun Dobson/Jenny Wyllie Mary-Jane Elliot / Sarah MacLeod / +44 20 32057500 Claire Dickinson [email protected] +44 20 7920 2342 [email protected] [email protected]

XLON

---

Related Shares:

SLN.L